Obesity
7,517
642
946
4,982
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
876 trials with published results (12%)
Research Maturity
4982 completed trials (66% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.0%
299 terminated out of 7517 trials
94.3%
+7.8% vs benchmark
9%
670 trials in Phase 3/4
18%
876 of 4982 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4982 completed trials
Clinical Trials (7517)
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Continuous Wearable Biometric Monitoring in Adults Undergoing Obesity Treatment (SMART-BMI)
Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity
A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body
Effect of PDE5 Inhibition on Adipose Metabolism in Humans
A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools
Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults
The Food Intake Phenotype: Assessing Eating Behavior and Food Preferences as Risk Factors for Obesity
A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
A Study of Econoglutide Injection in Obese Participants With Knee Osteoarthritis (KOA)
Bariatric Surgery Combined With GLP-1RA: A Multicenter Study.
A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity
A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy
Effect of a Single Nutritional Intervention Previous to a Critical Period of Fat Gain in University Students With Overweight and Obesity
New Heart Imaging Techniques to Evaluate Possible Heart Disease
Short-Term Changes in Salivary IL-6, TNF-α, and Periodontal Inflammation Following Sleeve Gastrectomy in Patients With Obesity: A Randomized Controlled Pilot Study